You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

415 Results
Guidelines and Advice
Status: In-Review
ID: GL 2-33
Jun 2022
Regimen
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Funding:
ODB - General Benefit
    relugolix
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
relugolix
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
May 2025
Guidelines and Advice
Status: In-Review
ID: 26-4
Jun 2015
Drug
Other Name(s): Orgovyx®
Quick Link(s): Drug Monograph, Patient Info Sheet
May 2025
Drug
Other Name(s): Neupogen®, Grastofil®, Nivestym®, Nypozi®
Quick Link(s): Drug Monograph, Patient Info Sheet
May 2025
This page lists cancer resources to support First Nations, Inuit, Métis and urban Indigenous communities and organizations in Ontario. Find tools,...
Cette page présente une liste des ressources sur le cancer visant à aider les collectivités et les organismes des Premières Nations, des Inuits, des...
Drug
Other Name(s): Rituxan® , Truxima™ , Riximyo™ , Ruxience™ , Riabni™
Quick Link(s): Drug Monograph, Patient Info Sheet
Updated
Jun 2025
Drug
Other Name(s): Rituxan® SC
Quick Link(s): Drug Monograph, Patient Info Sheet
Updated
Jun 2025
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's Low Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
riTUXimab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Updated
Jun 2025

Pages